These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 5714058

  • 1. [Evaluation of the antigastrin effect of xilamide].
    Laudano OM.
    Prensa Med Argent; 1968 Nov 29; 55(40):1896-8. PubMed ID: 5714058
    [No Abstract] [Full Text] [Related]

  • 2. Antigastrin suppression of gastrin, histamine, and vagal gastric secretion.
    Tiongco R, Isaza J, Sugawara K, Eisenberg MM.
    Surg Forum; 1968 Nov 29; 19():280-2. PubMed ID: 5718630
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacological studies on an antigastrin and antiulcer agent, SC-15396.
    Bianchi RG, Cook DL.
    Fed Proc; 1968 Nov 29; 27(6):1331-6. PubMed ID: 5725225
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of xylamide on basal gastric secretion and secretion stimulated by Histalog and food, in patients with duodenal ulcer].
    Bicalho SA, Silvério JB, Castro Lde P.
    AMB Rev Assoc Med Bras; 1971 Jan 29; 17(1):11-4. PubMed ID: 5314518
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Inhibiting effects of Xylamide on induced maximal gastric acid secretion in humans].
    Sampietro R.
    Minerva Med; 1969 Mar 21; 60(23):1032-7. PubMed ID: 5781329
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Gastrointestinal hormones and their clinical significance].
    Diwok K.
    Z Gesamte Inn Med; 1970 Apr 15; 25(8):330-7. PubMed ID: 4943128
    [No Abstract] [Full Text] [Related]

  • 12. Gastrointestinal effects of long-term treatment of duodenal ulcer with depot secretin: clinical, secretory, ultra-structural, and enzymological aspects.
    Demling L, Domschke W, Riemann JF, Domschke S, Ruppin H, Junge O, Wünsch E.
    Scand J Gastroenterol Suppl; 1976 Apr 15; 42():136-45. PubMed ID: 796967
    [No Abstract] [Full Text] [Related]

  • 13. [Activity-structure relationship in compounds with antigastrin activity].
    Andrási F, Borsy J, Farkas L.
    Acta Pharm Hung; 1973 Jul 15; 43(3):116-20. PubMed ID: 4747707
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Preoperative gastric secretion in patients with gastric or duodenal ulcer.
    Liavåg I, Havig O.
    Acta Chir Scand; 1969 Jul 15; 135(3):221-8. PubMed ID: 5803964
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Current procedures for the study of gastric chemistry. IV. Pentagastrin by inhalation to stimulate gastric secretion].
    Meeroff JC, Garcia Ben M, Meeroff M, Marchewski N, Rofrano J.
    Rev Esp Enferm Apar Dig; 1970 Mar 01; 30(5):537-50. PubMed ID: 5435375
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Failure of "antigastrin" (SC-15 396) to inhibit gastric acid and pepsin secretion in anaesthetized gastric fistula cats.
    Sewing KF, Gorinsky PD, Lembeck F.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968 Mar 01; 261(1):89-92. PubMed ID: 4236859
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.